REG - Provexis PLC - Result of AGM

ProvexisAnnouncement

04/10/2019 13:20

RNS Number : 8597O
Provexis PLC
04 October 2019
 


4 October 2019
 
Provexis plc
 
("Provexis" or the "Company")
 
Result of AGM
 
Provexis, the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient, announces that at the Company's Annual General Meeting, held earlier today, all resolutions were passed on a show of hands. The proxy votes received from shareholders on each resolution are set out below.
 



Resolutions


Votes for
*


%


Votes against
 


%


Votes total
**


Votes withheld
***




Resolution 1


236,549,625


99.99


13,361


0.01


236,562,986


300,000




Resolution 2


236,275,612


100.00


1,240


0.00


236,276,852


586,134




Resolution 3


236,158,555


99.98


41,763


0.02


236,200,318


662,668




Resolution 4


236,275,612


100.00


1,240


0.00


236,276,852


586,134




Resolution 5


234,736,711


99.33


1,592,616


0.67


236,329,327


533,659




Resolution 6


231,213,811


97.85


5,088,982


2.15


236,302,793


560,193




Resolution 7


230,838,811


97.59


5,695,166


2.41


236,533,977


329,009




Resolution 8


235,036,711


99.45


1,292,616


0.55


236,329,327


533,659



 



*


Includes discretionary votes




**


Total votes cast do not include withheld votes




***


A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' any of the resolutions



 
For further information please contact:
 



Provexis plc
Dawson Buck, Chairman
Ian Ford, CEO & CFO
 


Tel:        07490 391888
                enquiries@provexis.com




Allenby Capital Limited
Nick Naylor / Liz Kirchner


Tel:        020 3328 5656
 



 
 
Notes for editors
 
About Provexis plc
AIM-listed Provexis is focused on the development, licensing and sales of its proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient.
 
Provexis was founded in 1999 and is headquartered in Reading, Berkshire.
 
Provexis shares are traded on the AIM market of the London Stock Exchange under the ticker symbol PXS.
 
For further information, please visit www.provexis.com and www.fruitflowplus.com.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGLZLFBKBFFFBD